(Q44965057)

7 December 2017

title

Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys (English)

1 reference

7 December 2017

0 references

0 references

K Pyörälä

1

1 reference

7 December 2017

S Lehto

2

1 reference

7 December 2017

D De Bacquer

3

1 reference

7 December 2017

J De Sutter

4

1 reference

7 December 2017

S Sans

5

1 reference

7 December 2017

U Keil

6

1 reference

7 December 2017

D Wood

7

1 reference

7 December 2017

G De Backer

8

1 reference

7 December 2017

EUROASPIRE I and II Groups*

9

1 reference

7 December 2017

publication date

2 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

47

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1257-1265

1 reference

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-004-1438-Z

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

21 January 2018

1 reference

12 December 2020

Timolol Treatment After Myocardial Infarction in Diabetic Patients

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study

1 reference

12 December 2020

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

1 reference

12 December 2020

Diabetes and atherosclerosis: an epidemiologic view

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe

1 reference

12 December 2020

Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators

1 reference

12 December 2020

Mortality, mode of death and risk indicators for death during 5 years after coronary artery bypass grafting among patients with and without a history of diabetes mellitus

1 reference

12 December 2020

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

12 December 2020

The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study

1 reference

12 December 2020

Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study

1 reference

12 December 2020

The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it?

1 reference

12 December 2020

Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

12 December 2020

10.1007/S00125-004-1438-Z

Identifiers

DOI

1 reference

7 December 2017

1 reference